Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tigertriever 17 Ultra Revascularization Device

K-Number: K251603 · 2025-10-06

ApplicantRapid Medical , Ltd.
Decision Date2025-10-06
Product CodeNRY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Tigertriever 17 Ultra Revascularization Device is a medical device manufactured by Rapid Medical , Ltd.. It received FDA 510(k) clearance on 2025-10-06 under approval number K251603. The device is classified under product code NRY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tigertriever 17 Ultra Revascularization Device?

Tigertriever 17 Ultra Revascularization Device is a medical device that received FDA 510(k) clearance on 2025-10-06. It is manufactured by Rapid Medical , Ltd.. The 510(k) number is K251603.

When was Tigertriever 17 Ultra Revascularization Device approved by the FDA?

Tigertriever 17 Ultra Revascularization Device received FDA 510(k) clearance on 2025-10-06, under approval number K251603.

What company makes Tigertriever 17 Ultra Revascularization Device?

Tigertriever 17 Ultra Revascularization Device is manufactured by Rapid Medical , Ltd..

What is the FDA product code for Tigertriever 17 Ultra Revascularization Device?

The FDA product code for Tigertriever 17 Ultra Revascularization Device is NRY.

Related Clinical Trials

NCT05313555 The Effect of Violet Device Dosed Ultra Violet-C Light (UV-C) Exposure on Healthy Hand Skin TERMINATED NCT07588243 A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth RECRUITING NCT07604922 Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease NOT_YET_RECRUITING NCT07226193 Detecting Peripheral Artery Disease With the Pulse RECRUITING NCT07583706 A Single-center, Single-arm Study to Evaluate the Safety and Efficacy of Ultra-minimally Invasive Prostate Dilation in Treating Patients With Significant Obstructive Symptoms Caused by Benign Prostatic Hyperplasia RECRUITING NCT05650411 Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM) RECRUITING

Other Devices by Rapid Medical , Ltd.

K203592Tigertriever and Tigertriever 17 Revascularization Devce K220808Tigertriever 13 Revascularization Device K230429Tigertriever 21 Revascularization Device, Tigertriever 17 Revascularization Device, Tigertriever 13 Revascularization Device DEN230064BraidE Embolization Assist Device K253062Tigertriever 25 Revascularization Device

Related Devices (Code: NRY)

K161879Solitaire Platinum Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular K161640Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc. K161064Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc. K160449Penumbra System, Penumbra Pump MAXPenumbra, Inc. K152541Penumbra System ACE 64 and ACE 68 Reperfusion CathetersPenumbra, Inc. K172448Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑